The Patent Finder

Maintenance fees coming due

Celgene Corporation

58 maintenance fees come due in the 12 months from Nov 16, 2026, the next on Nov 30, 2026. Unpaid by Jun 1, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 11,660,297Antiproliferative Compounds and Second Active Agents for Combined Use
In force
Fee due Nov 30, 2026
Lapses if unpaid Jun 1, 2027
 · High confidence
Celgene CorporationIn forceNov 30, 2026Jun 1, 2027High confidence
US 11,660,3023-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-Dione for the Treatment of Systemic Lupus Erythematosus
In force
Fee due Nov 30, 2026
Lapses if unpaid Jun 1, 2027
 · High confidence
Celgene CorporationIn forceNov 30, 2026Jun 1, 2027High confidence
US 11,666,579Methods of Treating Hematological Malignancies Using 2-(2,6-Dioxopiperidin-3-YL)-4-((2-Fluoro-4-((3-Morpholinoazetidin-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-Dione
In force
Fee due Dec 6, 2026
Lapses if unpaid Jun 7, 2027
 · High confidence
Celgene CorporationIn forceDec 6, 2026Jun 7, 2027High confidence
US 9,051,110Packaging for Medicine for Clinical Trials or Commercial Use
In force
Fee due Dec 9, 2026
Lapses if unpaid Jun 9, 2027
 · High confidence
Celgene CorporationIn forceDec 9, 2026Jun 9, 2027High confidence
US 10,328,077Treatment of Relapsed And/Or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
In force
Fee due Dec 25, 2026
Lapses if unpaid Jun 25, 2027
 · Medium confidence
Celgene Quanticel Research, Inc.In forceDec 25, 2026Jun 25, 2027Medium confidence
US 10,335,495Biomolecule Conjugates
In force
Fee due Jan 2, 2027
Lapses if unpaid Jul 2, 2027
 · High confidence
Celgene CorporationIn forceJan 2, 2027Jul 2, 2027High confidence
US 10,338,077Methods for Determining Drug Efficacy for Treatment of Cancer Using Ratios of Cereblon Associated Proteins
In force
Fee due Jan 2, 2027
Lapses if unpaid Jul 2, 2027
 · High confidence
Celgene CorporationIn forceJan 2, 2027Jul 2, 2027High confidence
US 11,701,362Compositions and Methods of Use of CIS-4-[2-{[(3S,4R)-3-Fluorooxan-4-YL]AMINO}-8-(2,4,6-Trichloroanilino)-9H-PURIN-9-YL]-1-Methylcyclohexane-1-Carboxamide
In force
Fee due Jan 18, 2027
Lapses if unpaid Jul 19, 2027
 · Low confidence
Celgene CorporationIn forceJan 18, 2027Jul 19, 2027Low confidence
US 10,357,489Antiproliferative Compounds and Methods of Use Thereof
In force
Fee due Jan 23, 2027
Lapses if unpaid Jul 23, 2027
 · High confidence
Celgene CorporationIn forceJan 23, 2027Jul 23, 2027High confidence
US 9,096,5736-, 7-, or 8-Substituted Quinazolinone Derivatives and Compositions Comprising and Methods of Using the Same
In force
Fee due Feb 4, 2027
Lapses if unpaid Aug 4, 2027
 · High confidence
Celgene CorporationIn forceFeb 4, 2027Aug 4, 2027High confidence
48 more maintenance fees coming due in the 12 months from Nov 16, 2026 · Pro
10 of 58 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Upgrade to Pro
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited